MedPath

TAP Block With Two Different Doses of Levobupivacaine

Phase 4
Conditions
Pain, Postoperative
Interventions
Registration Number
NCT02567487
Lead Sponsor
Ankara University
Brief Summary

The aim of the current study is to investigate the effects of two different doses of levobupivacaine in TAP (transversus abdominus plane) block for postoperative management. For this purpose we planned to include 50 children aged between 2 and 12 that will undergo unilateral inguinal surgery.

The doses that will be used in the study were within usual dose limits which is stated in prospectus of the study drug.

Detailed Description

Fifty children undergoing TAP block were randomly divided into two groups as levobupivacaine 0.25% 0.5 ml/kg and levobupivacaine 0.25% 0.25 ml/kg. Postoperative pain was evaluated with observational pain scale and modified pediatric objective pain scale.

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
50
Inclusion Criteria
  • Volunteers planned to undergo unilateral inguinal surgery under TAP (ilioinguinal and iliohypogastric block) and general anesthesia
  • Aged between 2 and 12
Exclusion Criteria
  • Patients with coagulation dysfunction
  • Patients with chronic pain
  • Patients having infection at the site of intervention
  • Patients with a history of allergy
  • Patients having chronic diseases (hepatic dysfunction, renal failure)

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Group Levobupivacaine high volumeLevobupivacaineTAP block with levobupivacaine 0.25% of 0.5 ml/kg under general anesthesia
Group Levobupivacaine low volumeLevobupivacaineTAP block with levobupivacaine 0.25% of 0.25 ml/kg under general anesthesia
Primary Outcome Measures
NameTimeMethod
postoperative VAS score <4 at postoperative 24 hoursPostoperative first 24 hours
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath